Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech identifies novel Janus kinase inhibitors

Feb. 22, 2010

Novel IGF-1R inhibitors disclosed by IRM

Feb. 22, 2010

Phase I data show safety of proapoptotic receptor agonist antibody in advanced malignancies

Feb. 22, 2010

FDA grants orphan drug status to EntreMed's ENMD-2076 for acute myeloid leukemia

Feb. 19, 2010

FDA grants priority review to Novartis' Tasigna for newly diagnosed Ph+CML

Feb. 19, 2010

Chugai licenses Roche's Hedgehog pathway inhibitor RG-3616 in Japan

Feb. 19, 2010

PLK-1 inhibitors for the treatment of cancer described by Roche

Feb. 19, 2010

Merck KGaA discloses novel SphK1 and Met kinase inhibitors

Feb. 18, 2010

Georgetown University discloses MLCP inhibitors for cancer therapy

Feb. 18, 2010

Crystal structure of PI3Kdelta in complex with inhibitors allows design of enhanced agents

Feb. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...